First experience with the therapy of chronic hepatitis C in a HIV-positive patient;První zkušenosti s léčbou chronické hepatitidy C u HIV-pozitivního nemocného

Vnitrni Lekarstvi

Volumn 49, Issue 7, 2003, Pages 576-579

  Husa, Petr ^a   Snopkova S ^b   Chalupa, P ^b  

^a UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^b NONE

Author keywords

Co infection HIV HCV; Combined therapy by alpha inerferon and ribavirin; Undesirable effects

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; ANTIRETROVIRUS AGENT; EFAVIRENZ; HEMOGLOBIN; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; RIBAVIRIN; VIRUS RNA; ZIDOVUDINE;

ADULT; ARTICLE; CASE REPORT; ENZYME ACTIVITY; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MALE; SERUM; UKRAINE; AIDS RELATED COMPLEX; MIDDLE AGED;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED;

EID: 0043238838     PISSN: 0042773X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Sulkowski, M. S.: Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus. Clin. Inf. Dis., 30, 2000, S77-S84
2. Eyster, M. E., Diamondstone, L. S., Lien, J. M. et al.: Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study. J. Acquir. Immune Defic. Syndr., 6, 1993, 602-610
3. Telfer, P., Sabin, C., Devereux, H. et al.: The progression of HCV-associated liver disease in a cohort study of a hemophiliacs patients. Br. J. Hematol., 87, 1994, 555-561
4. Benhamou, Y., Bochet, M., Di Martino, V. et al.: Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients: the Multivirc Group. Hepatology, 30, 1999, 1048-1054
5. Puoti, M., Bonacini, M., Spinetti, A. et al.: Liver fibrosis progression is related to CD4 cell depletion in patients coinfected with hepatitis C virus and HIV. J. Inf. Dis., 183, 2001, 134-137
6. Soriano, V., Sulkowski, M., Bergin, C. et al.: Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV-HCV International Panel. AIDS, 16, 2002, 813-828
7. EASL International Consensus Conference on Hepatitis C. Consensus Statement. J. Hepatol., 30, 1999, 6, 956-961
8. National Institutes of Health: Consensus Development Conference Statement. Management of Hepatitis C: 2002. June 10-12, 2002. Hepatology, 36, 2002, 5, suppl. 1. Dostupné na http://consensus.nih.gov/cons/116/116cdc_intro.htm.
9. Doriano, V., Garcia-Samaniego, J.: Management of HIV/HCV co-infection. In: Arroyo V., Bosch J., Bruix J., Ginés P., Navasa, M., Rodés J., eds.: Therapy in Hepatology. Barcelona: Ars Medica 2001, 245-250